Cargando…
374 Therapeutic Class Labeling of EGFR Companion Diagnostics (CDxs)
OBJECTIVES/GOALS: Review all approved companion diagnostics (CDxs) labeling for therapeutic class language. Examine the regulatory pathways of CDx products whose labels contain therapeutic class labeling. Develop recommendations for pharmaceutical industry professionals on best practices in the co-d...
Autores principales: | Chen, Joyce, Cooper, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209237/ http://dx.doi.org/10.1017/cts.2022.213 |
Ejemplares similares
-
424 Considerations Mid-Translation of a Novel Extracellular Vesicle Product in Myocarditis
por: Beetler, Danielle, et al.
Publicado: (2022) -
431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia
por: Yoeli, Dor, et al.
Publicado: (2022) -
327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65
por: Joyce, Elizabeth, et al.
Publicado: (2022) -
408 In vivo calcium imaging in the medial prefrontal cortex reveals novel site of action for therapeutic effects of Neuromedin U
por: Miller, Sierra N., et al.
Publicado: (2022) -
241 Utilizing real-world evidence to increase efficiency of randomized controlled trials with application to repurposed therapeutics for COVID-19
por: Haine, Lillian M F, et al.
Publicado: (2022)